Zimmer Biomet Holdings Inc vs Zscaler Inc — how do they compare? Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B), while Zscaler Inc trades at $148.6 (market cap $24.23B). The key difference: Zscaler Inc is the larger of the two by market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while Zscaler Inc pays none. Which is the better fit depends on your goals.
| ZBH | ZS | |
|---|---|---|
Market Cap | $17.36B | $24.23B |
Sector | Health | Technology |
52-Week High | $107.71 | $336.27 |
52-Week Low | $79.58 | $118.05 |
Enterprise Value | $24.40B | $22.55B |
Dividend Yield | 1.07% | — |
Trailing returns across standard periods
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →